NURL:CSE, NeuralThera

NURL stock overview

NeuralThera (NURL:CSE) closed at $0.005 on November 18, 2026, unchanged on the day. It is trading at its 52-week low of $0.005. Over the past year, it lost 80.0%. NeuralThera is part of the Health Care sector.

Key figures

Price
$0.005
Day change
0.00%
Volume
0
Average volume
67,344
Market cap
846K+
52-week range
$0.005 – $0.030
50-day average
$0.013
200-day average
$0.014

Price action over the past year

In 252 trading sessions since November 20, 2025, NURL closed higher on 26 days (10%). Its best day was December 10, 2025 (+66.67%) and its worst was November 11, 2026 (-50.00%). The stock moved 10% or more in a single session 56 times. It opened at least 5% above the previous day's high 20 times.

Recent signals

NURL news

About NeuralThera

Neural Therapeutics is an ethnobotanical drug discovery company, focusing on the development of therapeutic drugs for mental illnesses related to substance use disorders, including alcohol and opioid dependence. The Company's innovative approach to drug development involves the strategic use of sub-hallucinogenic doses of mescaline extract, enhancing safety and scalability while maintaining therapeutic efficacy.

Similar stocks

Find more stocks like NURL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.

Based on end-of-day data. For information only, not investment advice.